Augmentation of antitumor immunity by genetically engineered fibroblast cells to express both B7.1 and interleukin-7 (Q73795133)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10812232%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Augmentation of antitumor immunity by genetically engineered fibroblast cells to express both B7.1 and interleukin-7 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10812232%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

T S Kim

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10812232%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

S W Chung

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10812232%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

S Y Hwang

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10812232%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

language of work or name

English

0 references

publication date

1 June 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10812232%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10812232%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10812232%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10812232%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

2886-2894

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10812232%20AND%20SRC:MED&resulttype=core&format=json

Dendritic cells as adjuvants for immune-mediated resistance to tumors

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900061-X

7 January 2021

Molecular mechanisms used by tumors to escape immune recognition: immunogenetherapy and the cell biology of major histocompatibility complex class I.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900061-X

7 January 2021

Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900061-X

7 January 2021

Enhanced cytolytic activity of tumor infiltrating lymphocytes (TILs) derived from an ICAM-1 transfected tumor in a murine model

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900061-X

7 January 2021

Cytokine gene-modified vaccines in the therapy of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900061-X

7 January 2021

The role of dendritic cells in T cell activation.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900061-X

7 January 2021

Human dendritic cells express functional interleukin-7.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900061-X

7 January 2021

Tumor antigens recognized by T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900061-X

7 January 2021

Human tumor antigens recognized by T-cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900061-X

7 January 2021

Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900061-X

7 January 2021

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900061-X

7 January 2021

Dendritic cell vaccines for cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900061-X

7 January 2021

Interleukin-7: biology and potential clinical applications

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900061-X

7 January 2021

Interleukin 7 enhances cytolytic T lymphocyte generation and induces lymphokine-activated killer cells from human peripheral blood

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900061-X

7 January 2021

Expression of murine interleukin 7 in a murine glioma cell line results in reduced tumorigenicity in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900061-X

7 January 2021

Interleukin 7 production and function in stromal cell-dependent B cell development

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900061-X

7 January 2021

Immunization with interleukin-2-secreting allogeneic mouse fibroblasts expressing melanoma-associated antigens prolongs the survival of mice with melanoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900061-X

7 January 2021

Antigen-specific cytotoxicity and cell number of adoptively transferred T cells are efficiently maintained in vivo by re-stimulation with an antigen/interleukin-2 fusion protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900061-X

7 January 2021

Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900061-X

7 January 2021

Combination gene therapy for liver metastasis of colon carcinoma in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900061-X

7 January 2021

Intratumoral coinjection of adenoviral vectors expressing IL-2 and IL-12 results in enhanced frequency of regression of injected and untreated distal tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900061-X

7 January 2021

Tumor cells cotransfected with interleukin-7 and B7.1 genes induce CD25 and CD28 on tumor-infiltrating T lymphocytes and are strong vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900061-X

7 January 2021

Tumor cells cotransduced with B7.1 and gamma-IFN induce effective rejection of established parental tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900061-X

7 January 2021

CD28/B7 system of T cell costimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900061-X

7 January 2021

10.1016/S0264-410X(00)00061-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10812232%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference